Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early vs late prophylactic enoxaparin in chronic subdural hematoma
IRCT20200207046400N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Mar 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of enoxaparin in venous thromboembolism (VTE) and thrombosis (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Incidence of thrombotic events and Incidence of hemorrhagic complications. Started Mar 2020; status: completed.
02
Drugs
enoxaparin
03
Conditions
venous thromboembolism (VTE)thrombosis
Beyond the preview
Go deeper on IRCT20200207046400N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200207046400N1.